Hosted on MSN
Syncom Formulations (India) Ltd Reports Stellar Growth in Q4 and FY 2024-25 Results; Profit After Tax Surges by 139%
Syncom Formulations (India) Limited, a leading name in the Indian pharmaceutical sector specialising in high-quality pharmaceutical formulations, has announced an outstanding performance for the ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
14 Aug, 2015 AGM Rs.0.0200 per share(2%)Dividend 13 Aug, 2014 AGM Rs.0.0200 per share(2%)Dividend ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results